losartan and arachidonic acid

losartan has been researched along with arachidonic acid in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Escalante, B; López-Sánchez, P; Martínez-Ayala, S; Rios, A; Sánchez-Mendoza, A; Vázquez-Cruz, B	1
Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A	1
Böger, RH; Drexler, H; Forssmann, WG; Krämer, C; Luchtefeld, M; Schieffer, B; Schmidt, B; Sunkomat, J; Tsikas, D; Walden, M; Witte, J	1
Ferrario, CM; Gallagher, PE; Richmond, RS; Strawn, WB; Tallant, EA	1
Lanting, L; Li, Z; Natarajan, R; Rodriguez-Iturbe, B; Sepassi, L; Vaziri, ND; Xu, ZG	1
Espinosa, EV; Khasawneh, FT; Murad, JP; Ting, HJ	1

Trials

1 trial(s) available for losartan and arachidonic acid

Article	Year
Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circulation research, 2002, Apr-19, Volume: 90, Issue:7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arachidonic Acid; Biotransformation; Cells, Cultured; Cyclooxygenase 2; Dinoprost; Drug Design; Endothelium, Vascular; Enzyme Activation; Female; Humans; Hypertension; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Isoenzymes; Lipopolysaccharides; Losartan; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Thromboxane A2; Up-Regulation; Vasoconstrictor Agents	2002

Article

Year

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

Circulation research, 2002, Apr-19, Volume: 90, Issue:7

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arachidonic Acid; Biotransformation; Cells, Cultured; Cyclooxygenase 2; Dinoprost; Drug Design; Endothelium, Vascular; Enzyme Activation; Female; Humans; Hypertension; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Isoenzymes; Lipopolysaccharides; Losartan; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Thromboxane A2; Up-Regulation; Vasoconstrictor Agents

2002

Other Studies

5 other study(ies) available for losartan and arachidonic acid

Article	Year
Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites. Biochemical and biophysical research communications, 2000, Jun-07, Volume: 272, Issue:2 Topics: Adrenalectomy; Angiotensin II; Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Indomethacin; Ion Transport; Kidney Tubules, Proximal; Losartan; Male; Ouabain; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes	2000
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:3 Pt 2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation	2001
Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2004, Volume: 5, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arachidonic Acid; Bone Marrow Cells; Cells, Cultured; Humans; Imidazoles; Losartan; Macaca fascicularis; Macrophage Colony-Stimulating Factor; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stromal Cells	2004
Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation, 2005, Apr-19, Volume: 111, Issue:15 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arachidonic Acid; Enzymes; Glomerulonephritis, Membranous; Inflammation Mediators; Kidney; Losartan; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; RNA, Messenger; Up-Regulation	2005
Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan. Journal of cardiovascular pharmacology and therapeutics, 2012, Volume: 17, Issue:3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Antihypertensive Agents; Arachidonic Acid; Blood Coagulation; Carotid Artery Injuries; Losartan; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Receptors, Thromboxane A2, Prostaglandin H2; Thrombosis	2012